Dr. Reddy's Laboratories Limited (BOM: 500124)
6,611.10
-40.75 (-0.61%)
At close: Sep 11, 2024
Dr. Reddy's Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Revenue | 288,507 | 279,164 | 245,879 | 214,391 | 189,722 | 174,600 | Upgrade
|
Revenue Growth (YoY) | 10.49% | 13.54% | 14.69% | 13.00% | 8.66% | 13.49% | Upgrade
|
Cost of Revenue | 118,109 | 115,557 | 106,536 | 100,551 | 86,645 | 80,591 | Upgrade
|
Gross Profit | 170,398 | 163,607 | 139,343 | 113,840 | 103,077 | 94,009 | Upgrade
|
Selling, General & Admin | 82,190 | 77,201 | 68,026 | 62,081 | 54,650 | 50,129 | Upgrade
|
Research & Development | 24,082 | 22,873 | 19,381 | 17,482 | 16,541 | 15,410 | Upgrade
|
Other Operating Expenses | -1,474 | -1,775 | -1,480 | -1,642 | -1,024 | -843 | Upgrade
|
Operating Expenses | 104,798 | 98,299 | 85,927 | 77,921 | 70,167 | 64,696 | Upgrade
|
Operating Income | 65,600 | 65,308 | 53,416 | 35,919 | 32,910 | 29,313 | Upgrade
|
Interest Expense | -1,938 | -1,711 | -1,428 | -958 | -970 | -983 | Upgrade
|
Interest & Investment Income | 2,693 | 2,278 | 1,180 | 965 | 826 | 888 | Upgrade
|
Earnings From Equity Investments | 163 | 147 | 370 | 703 | 480 | 561 | Upgrade
|
Currency Exchange Gain (Loss) | -21 | 278 | 2,225 | 1,835 | 1,240 | 639 | Upgrade
|
Other Non Operating Income (Expenses) | 46 | 46 | -152 | 277 | 557 | 5 | Upgrade
|
EBT Excluding Unusual Items | 66,543 | 66,346 | 55,611 | 38,741 | 35,043 | 30,423 | Upgrade
|
Gain (Loss) on Sale of Investments | 3,267 | 3,103 | 1,028 | - | - | 929 | Upgrade
|
Gain (Loss) on Sale of Assets | 891 | 900 | -1,211 | 1,119 | -42 | -10 | Upgrade
|
Asset Writedown | 3 | -3 | -699 | -7,562 | -8,588 | -16,767 | Upgrade
|
Legal Settlements | 1,524 | 1,524 | 5,638 | - | - | - | Upgrade
|
Other Unusual Items | - | - | - | - | - | 3,457 | Upgrade
|
Pretax Income | 72,228 | 71,870 | 60,367 | 32,298 | 26,413 | 18,032 | Upgrade
|
Income Tax Expense | 16,649 | 16,186 | 15,300 | 8,730 | 9,175 | -1,466 | Upgrade
|
Earnings From Continuing Operations | 55,579 | 55,684 | 45,067 | 23,568 | 17,238 | 19,498 | Upgrade
|
Net Income | 55,579 | 55,684 | 45,067 | 23,568 | 17,238 | 19,498 | Upgrade
|
Net Income to Common | 55,579 | 55,684 | 45,067 | 23,568 | 17,238 | 19,498 | Upgrade
|
Net Income Growth | 17.71% | 23.56% | 91.22% | 36.72% | -11.59% | 3.74% | Upgrade
|
Shares Outstanding (Basic) | 166 | 166 | 166 | 166 | 166 | 166 | Upgrade
|
Shares Outstanding (Diluted) | 167 | 167 | 166 | 166 | 166 | 166 | Upgrade
|
Shares Change (YoY) | 0.20% | 0.19% | 0.03% | 0.01% | 0.14% | -0.07% | Upgrade
|
EPS (Basic) | 333.84 | 334.65 | 271.43 | 142.08 | 103.94 | 117.63 | Upgrade
|
EPS (Diluted) | 333.26 | 334.02 | 270.85 | 141.69 | 103.65 | 117.40 | Upgrade
|
EPS Growth | 17.48% | 23.32% | 91.16% | 36.70% | -11.71% | 3.81% | Upgrade
|
Free Cash Flow | 24,805 | 29,030 | 47,552 | 13,448 | 25,962 | 24,995 | Upgrade
|
Free Cash Flow Per Share | 148.74 | 174.14 | 285.79 | 80.85 | 156.10 | 150.50 | Upgrade
|
Dividend Per Share | 40.000 | 40.000 | 40.000 | 30.000 | 25.000 | 25.000 | Upgrade
|
Dividend Growth | 0% | 0% | 33.33% | 20.00% | 0% | 25.00% | Upgrade
|
Gross Margin | 59.06% | 58.61% | 56.67% | 53.10% | 54.33% | 53.84% | Upgrade
|
Operating Margin | 22.74% | 23.39% | 21.72% | 16.75% | 17.35% | 16.79% | Upgrade
|
Profit Margin | 19.26% | 19.95% | 18.33% | 10.99% | 9.09% | 11.17% | Upgrade
|
Free Cash Flow Margin | 8.60% | 10.40% | 19.34% | 6.27% | 13.68% | 14.32% | Upgrade
|
EBITDA | 79,539 | 79,006 | 65,173 | 47,743 | 45,706 | 41,785 | Upgrade
|
EBITDA Margin | 27.57% | 28.30% | 26.51% | 22.27% | 24.09% | 23.93% | Upgrade
|
D&A For EBITDA | 13,939 | 13,698 | 11,757 | 11,824 | 12,796 | 12,472 | Upgrade
|
EBIT | 65,600 | 65,308 | 53,416 | 35,919 | 32,910 | 29,313 | Upgrade
|
EBIT Margin | 22.74% | 23.39% | 21.72% | 16.75% | 17.35% | 16.79% | Upgrade
|
Effective Tax Rate | 23.05% | 22.52% | 25.34% | 27.03% | 34.74% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.